Klencke Barbara insider trades
Klencke Barbara has filed 26 Form 4s with the SEC that we hold, for TScan Therapeutics, Inc. (TCRX) (Director), EFTR (Director), Alx Oncology Holdings INC (ALXO) (Chief Medical Officer) and SRRA (Chief Medical Officer), among 5 companies in all. Across all of them we count 4 purchases worth $108.0K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 5,000 shares of TScan Therapeutics, Inc. worth $28.5K, dated 2024-08-23. The first filing on our record is dated 2021-11-02 and the latest 2026-07-08.
TScan Therapeutics, Inc. (TCRX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-12-14 | P, purchase reported on Form 4 | 5,000 | $25.4K | 2023-12-18 |
| 2024-08-23 | P, purchase reported on Form 4 | 5,000 | $28.5K | 2024-08-27 |
| 2024-08-26 | P, purchase reported on Form 4 | 5,000 | $27.6K | 2024-08-27 |
| 2024-09-23 | P, purchase reported on Form 4 | 5,000 | $26.4K | 2024-09-24 |
EFTR
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Alx Oncology Holdings INC (ALXO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
SRRA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Xencor Inc (XNCR)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1647647) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms